Biogen

NASDAQ
BIIB
Stock
Yield per half year: -3.25%
Dividend yield: 0%
Sector: Healthcare

132.87 $

-0.32 $ -0.2403%
113.38 $
236.8 $

Min/max per year

Share chart Biogen

About Biogen

Biogen Inc. — американская многонациональная биотехнологическая компания, базирующаяся в Кембридже, штат Массачусетс, специализирующаяся на открытии, разработке и поставке методов лечения нейродегенеративных, гематологических и аутоиммунных заболеваний пациентам во всем мире.

Main settings

IPO date
1991-09-16
ISIN
US09062X1037
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Дивиденд ао
22.23
Сайт

Grade

Underestimation
Title Value Grade
P/S 2.26 6
P/BV 1.31 9
P/E 13.43 8
Efficiency
Title Value Grade
ROA 5.95 2
ROE 10.36 4
ROIC 8.77 3
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0.5 5
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA 2.55 5
Debt/Ratio 0.2364 10
Debt/Equity 0.678 9
Growth impulse
Title Value Grade
Yield Revenue, % -28.01 0
Yield Ebitda, % -68.39 0
Yield EPS, % -54.89 0

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 133.19 $ 0 $ 0 $ -0.24 % 0 % 0 %
Week 126.92 $ 0 $ 0 $ 4.69 % 0 % 0 %
Month 131.86 $ 124.76 $ 133.19 $ 0.77 % 0 % 0 %
Three month 118.89 $ 115.17 $ 135.49 $ 11.76 % 0 % 0 %
Half a year 137.33 $ 113.38 $ 150.71 $ -3.25 % 0 % 0 %
Year 195.63 $ 113.38 $ 236.8 $ -32.08 % 0 % 0 %
3 years 200.62 $ 113.38 $ 324.5 $ -33.77 % 0 % 0 %
5 years 272.43 $ 113.38 $ 422.32 $ -51.23 % 0 % 0 %
10 years 280.48 $ 113.38 $ 422.32 $ -52.63 % 0 % 0 %
Year to date 142.54 $ 113.38 $ 153.27 $ -6.78 % 0 % 0 %

Insider trading

Insider Transaction date Date of disclosure Type Price Volume Quantity Share before, % Share after, % Document
Izzar Rachid
Officer
08.07.2025 08.07.2025 Purchase 135 300 105 2223 0 0 link
Gregory Ginger
EVP, Human Resources
07.02.2025 10.02.2025 Purchase 142.54 489 767 3436 0 0 link
ALEXANDER SUSAN H
EVP Chief Legal Officer
07.02.2025 10.02.2025 Purchase 142.54 588 690 4130 0 0 link
Singhal Priya
Head of Development
31.01.2025 03.02.2025 Purchase 143.93 263 104 1828 0 0 link
Singhal Priya
Head of Development
12.02.2024 13.02.2024 Sale 239.45 100 330 419 0 0 link
Izzar Rachid
Head of Global Product Strat.
09.02.2024 13.02.2024 Purchase 226.53 343 193 1515 0 0 link
Kramer Robin
Chief Accounting Officer
09.02.2024 13.02.2024 Purchase 226.53 188 699 833 0 0 link
MCDONNELL MICHAEL R
EVP, Chief Financial Officer
09.02.2024 13.02.2024 Purchase 226.53 737 808 3257 0 0 link
Murphy Nicole
Head of Pharm Ops and Tech
09.02.2024 13.02.2024 Purchase 226.53 514 676 2272 0 0 link
Singhal Priya
Head of Development
09.02.2024 13.02.2024 Purchase 226.53 274 554 1212 0 0 link
Gregory Ginger
EVP, Human Resources
09.02.2024 13.02.2024 Purchase 226.53 488 852 2158 0 0 link
Murphy Nicole
Head of Pharm Ops and Tech
08.02.2024 09.02.2024 Purchase 240.58 505 459 2101 0 0 link
MCDONNELL MICHAEL R
EVP, Chief Financial Officer
08.02.2024 09.02.2024 Purchase 240.58 561 754 2335 0 0 link
Kramer Robin
Chief Accounting Officer
08.02.2024 09.02.2024 Purchase 240.58 189 577 788 0 0 link
Izzar Rachid
Head of Global Product Strat.
08.02.2024 09.02.2024 Purchase 240.58 491 505 2043 0 0 link
Gregory Ginger
EVP, Human Resources
08.02.2024 09.02.2024 Purchase 240.58 393 348 1635 0 0 link
ALEXANDER SUSAN H
EVP Chief Legal Officer
08.02.2024 09.02.2024 Purchase 240.58 526 870 2190 0 0 link
Gregory Ginger
EVP, Human Resources
28.04.2023 02.05.2023 Sale 300 804 300 2681 0 0 link
Kramer Robin
Chief Accounting Officer
08.12.2022 12.12.2022 Purchase 289.47 101 315 350 0 0 link
ALEXANDER SUSAN H
EVP Chief Legal Off & Corp Sec
27.10.2022 28.10.2022 Sale 280.7 1 552 830 5532 0 0 link
BIOGEN INC.
10% Owner
30.08.2022 31.08.2022 Sale 5.27 527 000 100000 0 -0.07 link
BIOGEN INC.
10% Owner
29.08.2022 31.08.2022 Sale 5.33 2 132 000 400000 0 -0.27 link
Izzar Rachid
Head of Alzheimer's Disease
01.07.2022 06.07.2022 Purchase 215.98 108 854 504 0 0 link
Kramer Robin
Chief Accounting Officer
01.07.2022 06.07.2022 Purchase 215.98 54 427 252 0 0 link
Guindo Chirfi
Head of Glob Prod Strat & Com
07.06.2021 09.06.2021 Sale 440 1 358 280 3087 0 0 link
Sandrock Alfred
Head of Research & Development
07.06.2021 09.06.2021 Sale 440 3 375 680 7672 0 0 link
Posner Brian S
Director
04.06.2021 07.06.2021 Sale 274.17 98 701 360 0 0 link

Main owners

Institutions Volume Share, %
PRIMECAP Management Company 16 264 481 11.19
Vanguard Group Inc 14 407 330 9.91
Blackrock Inc. 14 246 658 9.8
State Street Corporation 6 945 665 4.78
T. Rowe Price Investment Management, Inc. 5 357 326 3.69
Wellington Management Group, LLP 5 324 396 3.66
JP Morgan Chase & Company 5 011 319 3.45
Geode Capital Management, LLC 3 309 317 2.28
Invesco Ltd. 1 814 666 1.25
ClearBridge Investments, LLC 1 679 302 1.16

Contained in ETF

Similar companies



Company management

Head Job title Payment Year of birth
Ms. Robin C. Kramer Senior VP & Chief Accounting Officer N/A 1966 (59 years)
Ms. Natacha Gassenbach Chief Communication Officer & Head of Corporate Affairs N/A
Ms. Nicole Murphy Head of Pharmaceutical Operations & Technology 1.46M 1973 (52 years)
Mr. Michael R. McDonnell CPA Executive VP & CFO 2.12M 1964 (61 year)
Ms. Susan H. Alexander Esq. Executive VP & Chief Legal Officer 2.2M 1957 (68 years)
Mr. Christopher A. Viehbacher President, CEO & Director 487.94k 1961 (64 years)
Mr. Charles E. Triano Senior VP & Head of Investor Relations N/A
Mr. Adam Keeney Ph.D. Executive VP & Head of Corporate Development N/A 1977 (48 years)
Mr. Rachid Izzar Head of Global Product Strategy & Commercialization 1975 (50 years)
Dr. Ginger Gregory Ph.D. Executive VP & Chief Human Resources Officer 1968 (57 years)

About company

Address: United States, Cambridge, 225 Binney Street - Open in google maps, Open in yandex maps
Website: http://www.biogen.com